Center for Nanoscale Materials and Biointegration, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Department of Material Science and Engineering, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.
J Mater Chem B. 2020 Apr 8;8(14):2814-2825. doi: 10.1039/c9tb02757b.
We report a novel and facile organosilane plasma polymerization method designed to improve the surface characteristics of poly(tetrafluoroethylene) (PTFE). We hypothesized that the polymerized silane coating would provide an adhesive surface for endothelial cell proliferation due to a large number of surface hydroxyl groups, while the large polymer networks on the surface of PTFE would hinder platelet attachment. The plasma polymerized PTFE surfaces were then systematically characterized via different analytical techniques such as FTIR, XPS, XRD, Contact angle, and SEM. The key finding of the characterization is the time-dependent deposition of an organosilane layer on the surface of PTFE. This layer was found to provide favorable surface properties to PTFE such as a very high surface oxygen content, high hydrophilicity and improved surface mechanics. Additionally, in vitro cellular studies were conducted to determine the bio-interface properties of the plasma-treated and untreated PTFE. The important results of these experiments were rapid endothelial cell growth and decreased platelet attachment on the plasma-treated PTFE compared to untreated PTFE. Thus, this new surface modification technique could potentially address the current challenges associated with PTFE for blood contact applications, specifically poor endothelial cell growth and risk of thrombosis.
我们报告了一种新颖且简便的有机硅烷等离子体聚合方法,旨在改善聚四氟乙烯(PTFE)的表面特性。我们假设聚合硅烷涂层会由于大量的表面羟基而提供有利于内皮细胞增殖的黏附表面,而 PTFE 表面上的大聚合物网络会阻碍血小板附着。然后通过不同的分析技术(例如 FTIR、XPS、XRD、接触角和 SEM)对等离子体聚合 PTFE 表面进行了系统的表征。表征的关键发现是在 PTFE 表面上的时间依赖性的有机硅烷层沉积。该层被发现为 PTFE 提供了有利的表面性能,例如非常高的表面氧含量、高亲水性和改善的表面力学性能。此外,进行了体外细胞研究以确定等离子体处理和未处理的 PTFE 的生物界面特性。这些实验的重要结果是与未经处理的 PTFE 相比,在等离子体处理的 PTFE 上内皮细胞生长迅速且血小板附着减少。因此,这种新的表面改性技术可能会解决与血液接触应用相关的 PTFE 的当前挑战,特别是内皮细胞生长不良和血栓形成的风险。